We have recently completed a 2-yr audit of our ward-based extradural analgesia service consisting of 515 cases. This was based on the work of Wheatley and colleagues [2] using the same assessment tools as were used in their study. In the past 12 months, however, we have discarded " pain at rest" as we actively encourage our patients to be mobile, and this indicator contradicts this approach. We also found it a poor indication of analgesic quality. The results of our audit are shown in tables 1 and 2.
Inhaled nitric oxide in acute respiratory failure
Sir,-I found the recent paper by Young and colleagues [1] interesting, although most of their findings are in agreement with previously published human studies. However, I believe there was a significant error in their calculation of venous admixture (QVA/QT). The values at first inspection appeared very low, particularly in the latter part of with 32 vpm and 0.34 (0.14) and 0.32 (0.14) with 128 vpm. All of these changes are significant (P < 0.05).
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Postoperative extradural analgesia
Sir,-We read with interest the recent article by Leith and colleagues [1] on the results of a 4-yr audit of 770 patients receiving postoperative extradural analgesia at York Hospital usinga mixture of 0.15% bupivacaine with 0.0O5 % diamorphine. Over the past 8 yr we have used different opioids at various strengths mixed with 0.125% bupivacaine in order to determine the most effective analgesia with the lowest incidence of major or minor complications. We have found that the best opioid to add to bupivacaine is fentanyl at a concentration of 8.3 ug ml" 1 (i.e. fentanyl 10 ml in a 60-ml syringe). The audit conducted in York showed that from 1990 to 1993, on average, 47 % of patients experienced moderate or severe pain on movement while our own audit of 515 patients over 2 yr had an incidence of 22.3% experiencing the same degree of pain on movement. The incidence of complications with our extradural mixture was also comparable; an incidence of respiratory depression (frequency less than 10 b.p.m.) of 3.0% compared with 2.6%. We found an incidence of vomiting of 12.4% compared with 16.8%, and an incidence of itching of 3.3% compared with 12% in the audit from York, and an incidence of hypotension of 1.4% compared with 34% with the diamorphine mixture.
There has been much discussion in the past on which opioid should be added to bupivacaine in order to provide the best quality analgesia, and the lowest complication rate. One such study by Enevery and colleagues [3] demonstrated that diamorphine was the more appropriate agent. This study used relatively small numbers (61 patients divided into three groups) and we suggest that the different results from these two extensive audits should stimulate further work in this area.
The interesting finding of our own audit was that patients in the over 80-yr age group had an incidence of respiratory depression of 8.6 % compared with 2.2 % in the under 80-yr age group. This has led us to halve the quantity of fentanyl in the analgesic mixture in all patients over 80 yr of age. The audit will be repeated after 12 months.
We feel that the results clearly support our choice of opioid, namely fentanyl, in our analgesic mixture. While we have demonstrated some differences between our two services, we would wholeheartedly support the conclusion, still refuted in some quarters, that the ward-based extradural service provides a high quality postoperative recovery.
